Literature DB >> 27584545

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.

Julia Greiser1, Tobias Niksch1, Wolfgang Weigand2, Martin Freesmeyer3.   

Abstract

We demonstrate a method for the isolation of EOB-DTPA (3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecanedioic acid) from its Gd(III) complex and protocols for the preparation of its novel non-radioactive, i.e., natural Ga(III) as well as radioactive (68)Ga complex. The ligand as well as the Ga(III) complex were characterized by nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry and elemental analysis. (68)Ga was obtained by a standard elution method from a (68)Ge/(68)Ga generator. Experiments to evaluate the (68)Ga-labeling efficiency of EOB-DTPA at pH 3.8-4.0 were performed. Established analysis techniques radio TLC (thin layer chromatography) and radio HPLC (high performance liquid chromatography) were used to determine the radiochemical purity of the tracer. As a first investigation of the (68)Ga tracers' lipophilicity the n-octanol/water distribution coefficient of (68)Ga species present in a pH 7.4 solution was determined by an extraction method. In vitro stability measurements of the tracer in various media at physiological pH were performed, revealing different rates of decomposition.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27584545      PMCID: PMC5091902          DOI: 10.3791/54334

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  33 in total

1.  Fluorine-18: a new isotope for bone scanning.

Authors:  M BLAU; W NAGLER; M A BENDER
Journal:  J Nucl Med       Date:  1962-07       Impact factor: 10.057

Review 2.  The role of coordination chemistry in the development of target-specific radiopharmaceuticals.

Authors:  Shuang Liu
Journal:  Chem Soc Rev       Date:  2004-08-16       Impact factor: 54.564

Review 3.  [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].

Authors:  C Stroszczynski; G Gaffke; M Gnauck; F Streitparth; G Wieners; E Lopez-Häninnen
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 4.  Asialoglycoprotein receptor-targeted radiopharmaceuticals for measurement of liver function.

Authors:  W Yang; X Zhang; Y Liu
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.

Authors:  Johannes Notni; Karolin Pohle; Hans-Jürgen Wester
Journal:  Nucl Med Biol       Date:  2012-09-18       Impact factor: 2.408

6.  Past, present and future of 68Ge/68Ga generators.

Authors:  F Rösch
Journal:  Appl Radiat Isot       Date:  2012-11-22       Impact factor: 1.513

7.  Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Authors:  M Hofmann; H Maecke; R Börner; E Weckesser; P Schöffski; L Oei; J Schumacher; M Henze; A Heppeler; J Meyer; H Knapp
Journal:  Eur J Nucl Med       Date:  2001-10-31

Review 8.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

9.  Development of ⁶⁸Ga-labelled DTPA galactosyl human serum albumin for liver function imaging.

Authors:  Roland Haubner; David R Vera; Salman Farshchi-Heydari; Anna Helbok; Christine Rangger; Daniel Putzer; Irene J Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-12       Impact factor: 9.236

10.  How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates?

Authors:  Jakub Šimeček; Petr Hermann; Hans-Jürgen Wester; Johannes Notni
Journal:  ChemMedChem       Date:  2012-11-07       Impact factor: 3.466

View more
  1 in total

Review 1.  Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver.

Authors:  Julia Greiser; Wolfgang Weigand; Martin Freesmeyer
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.